Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Pediatric radiologists skillfully read emergency breast ultrasound—but patients may shrug off discharge instructions

For this reason, these patients may need pointed guidance upon ED discharge lest cancers go undetected in early stages.  

UnitedHealth CFO sued in retirement plan case

The suit alleges the company’s 401(k) retirement plan invested in low-performing target-date funds in favor of its business relationship with Wells Fargo.

Thumbnail

FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system

This latest recall was initiated because electrical faults could cause the batteries to stop working, which leads to a risk of serious injury or death.

USPSTF highlights the benefits of statin use among high-risk CVD patients in new recommendations

The USPSTF recommends statin use for high-risk patients between the ages of 40 to 75 to help prevent a first heart attack or stroke. Other patients in that same age group may also benefit, the group noted, but physician input is needed. 

Thumbnail

Emergency trunk CT rises sharply even for minor, moderate trauma

Almost 10 of every 1,000 patients evaluated for trauma injuries in 2018 received CT scans of the chest, abdomen and pelvis to supply a diagnostic view of, in essence, the entire torso.

Dyad Medical Echo:Prio FDA

Regulatory Roundup: FDA approves new-look self-expanding stent, clears 2 advanced AI models

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

Thumbnail

Clinical evidence is limited in many AI product promotions, analysis shows

To promote the legitimacy of their products, companies most often tout their partnerships with medical and academic institutions, in addition to their applications’ legal approvals.

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.